ICOM
ABBV icon

Investment Counselors of Maryland’s AbbVie ABBV Stock Holding History

Investment Counselors of Maryland’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,235
Closed -$551K – 156
2020
Q1 		$551K Sell
7,235
-1,725
-19% -$147K 0.04% 133
2019
Q4 		$793K Buy
8,960
+50
+0.6% +$4.15K 0.03% 136
2019
Q3 		$675K Sell
8,910
-1,950
-18% -$134K 0.03% 134
2019
Q2 		$790K Buy
10,860
+650
+6% +$51.1K 0.04% 138
2019
Q1 		$823K Sell
10,210
-850
-8% -$69.5K 0.04% 136
2018
Q4 		$1.02M Sell
11,060
-25
-0.2% -$2.2K 0.06% 138
2018
Q3 		$1.05M Buy
11,085
+1,250
+13% +$119K 0.05% 139
2018
Q2 		$911K Sell
9,835
-475
-5% -$46.4K 0.04% 136
2018
Q1 		$976K Sell
10,310
-75
-0.7% -$8.24K 0.05% 135
2017
Q4 		$1M Sell
10,385
-675
-6% -$63.6K 0.05% 137
2017
Q3 		$983K Sell
11,060
-275
-2% -$20.9K 0.05% 137
2017
Q2 		$822K Sell
11,335
-75
-0.7% -$5.04K 0.04% 140
2017
Q1 		$743K Sell
11,410
-400
-3% -$25.1K 0.04% 146
2016
Q4 		$740K Sell
11,810
-100
-0.8% -$6.1K 0.04% 144
2016
Q3 		$751K Sell
11,910
-275
-2% -$17.8K 0.04% 147
2016
Q2 		$754K Hold
12,185
– – 0.04% 149
2016
Q1 		$696K Sell
12,185
-4,525
-27% -$252K 0.04% 146
2015
Q4 		$990K Sell
16,710
-3,325
-17% -$192K 0.06% 152
2015
Q3 		$1.09M Hold
20,035
– – 0.06% 155
2015
Q2 		$1.35M Sell
20,035
-350
-2% -$22.8K 0.06% 153
2015
Q1 		$1.19M Sell
20,385
-700
-3% -$42.3K 0.06% 147
2014
Q4 		$1.38M Sell
21,085
-2,250
-10% -$142K 0.07% 146
2014
Q3 		$1.35M Hold
23,335
– – 0.07% 149
2014
Q2 		$1.32M Hold
23,335
– – 0.06% 149
2014
Q1 		$1.2M Hold
23,335
– – 0.05% 153
2013
Q4 		$1.23M Hold
23,335
– – 0.05% 156
2013
Q3 		$1.04M Sell
23,335
-23,800
-50% -$1.06M 0.04% 164
2013
Q2 		$1.95M Buy
+47,135
New +$2.06M 0.09% 160

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Investment Counselors of Maryland's ABBV Position: Q2 2020 in Review

Investment Counselors of Maryland sold out of AbbVie (ABBV) in Q2 2020, closing a stake of 7,235 shares — an estimated $551K sold.

Investment Counselors of Maryland first reported a position in ABBV in Q2 2013 and held it in 28 quarters. The position peaked at $1.95M in Q2 2013. 2,412 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • Investment Counselors of Maryland reported no remaining AbbVie position as of Q2 2020 after selling out during the quarter.
  • Investment Counselors of Maryland sold 7,235 AbbVie shares in Q2 2020, an estimated $551K.
  • Investment Counselors of Maryland first reported a position in AbbVie in Q2 2013 and held it in 28 quarters.
  • Investment Counselors of Maryland's AbbVie position peaked at $1.95M in Q2 2013.
  • 2,412 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Investment Counselors of Maryland's 13F filing for Q2 2020, filed 7 Aug 2020.